These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 18155800

  • 1. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM, Griffin BT.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):617-24. PubMed ID: 18155800
    [Abstract] [Full Text] [Related]

  • 2. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):768-77. PubMed ID: 18077051
    [Abstract] [Full Text] [Related]

  • 3. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW, Porter CJ.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):625-37. PubMed ID: 18068260
    [Abstract] [Full Text] [Related]

  • 4. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
    Porter CJ, Pouton CW, Cuine JF, Charman WN.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):673-91. PubMed ID: 18155801
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
    Subramanian N, Ghosal SK.
    Indian J Exp Biol; 2004 Nov 17; 42(11):1056-65. PubMed ID: 15587110
    [Abstract] [Full Text] [Related]

  • 6. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A, Hoffman A.
    J Control Release; 2008 Jul 02; 129(1):1-10. PubMed ID: 18499294
    [Abstract] [Full Text] [Related]

  • 7. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ, Trevaskis NL, Charman WN.
    Nat Rev Drug Discov; 2007 Mar 02; 6(3):231-48. PubMed ID: 17330072
    [Abstract] [Full Text] [Related]

  • 8. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
    Porter CJ, Wasan KM, Constantinides P.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):615-6. PubMed ID: 18160174
    [No Abstract] [Full Text] [Related]

  • 9. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V, Musakhanian J, Marchaud D.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):734-46. PubMed ID: 18045728
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y, Porter W, Merdan T, Li LC.
    Expert Opin Drug Deliv; 2009 Dec 17; 6(12):1261-82. PubMed ID: 19941409
    [Abstract] [Full Text] [Related]

  • 11. What determines drug solubility in lipid vehicles: is it predictable?
    Rane SS, Anderson BD.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):638-56. PubMed ID: 18089295
    [Abstract] [Full Text] [Related]

  • 12. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H, Holm R, Müllertz A.
    Int J Pharm; 2013 Aug 30; 453(1):215-24. PubMed ID: 23578826
    [Abstract] [Full Text] [Related]

  • 13. Improving oral delivery.
    Gabor F, Fillafer C, Neutsch L, Ratzinger G, Wirth M.
    Handb Exp Pharmacol; 2010 Aug 30; (197):345-98. PubMed ID: 20217536
    [Abstract] [Full Text] [Related]

  • 14. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M, Nick S, Parrott N, Röthlisberger D.
    Eur J Pharm Sci; 2006 Jan 30; 27(1):91-9. PubMed ID: 16219449
    [Abstract] [Full Text] [Related]

  • 15. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP, Chaubal MV, Shorr R.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):757-67. PubMed ID: 18096269
    [Abstract] [Full Text] [Related]

  • 16. Oral lipid-based formulations.
    Hauss DJ.
    Adv Drug Deliv Rev; 2007 Jul 30; 59(7):667-76. PubMed ID: 17618704
    [Abstract] [Full Text] [Related]

  • 17. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S.
    Int J Pharm; 2011 Nov 25; 420(1):1-10. PubMed ID: 21884771
    [Abstract] [Full Text] [Related]

  • 18. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
    Pouton CW.
    Eur J Pharm Sci; 2006 Nov 25; 29(3-4):278-87. PubMed ID: 16815001
    [Abstract] [Full Text] [Related]

  • 19. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
    Chakraborty S, Shukla D, Mishra B, Singh S.
    Eur J Pharm Biopharm; 2009 Sep 25; 73(1):1-15. PubMed ID: 19505572
    [Abstract] [Full Text] [Related]

  • 20. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA, Kayser O, Müller RH.
    Adv Drug Deliv Rev; 2004 May 07; 56(9):1257-72. PubMed ID: 15109768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.